These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14708827)

  • 21. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
    De Vecchi AF; Dratwa M; Wiedemann ME
    Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist.
    Ifudu O; Dawood M; Homel P; Friedman EA
    Am J Kidney Dis; 1996 Dec; 28(6):841-5. PubMed ID: 8957035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: access to ESRD treatments.
    Hörl WH; de Alvaro F; Williams PF
    Nephrol Dial Transplant; 1999; 14 Suppl 6():10-5. PubMed ID: 10528707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure.
    Avorn J; Winkelmayer WC; Bohn RL; Levin R; Glynn RJ; Levy E; Owen W
    J Clin Epidemiol; 2002 Jul; 55(7):711-6. PubMed ID: 12160919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s?
    Ifudu O; Mayers JD; Matthew JJ; Macey LJ; Brezsnyak W; Reydel C; McClendon E; Surgrue T; Rao TK; Friedman EA
    Am J Kidney Dis; 1997 Apr; 29(4):549-52. PubMed ID: 9100043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998-2005.
    Stankuvienė A; Ziginskienė E; Kuzminskis V; Bumblytė IA
    Medicina (Kaunas); 2010; 46(8):516-21. PubMed ID: 20966627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular access placement in patients with chronic kidney disease Stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers.
    Goel N; Kwon C; Zachariah TP; Broker M; Folkert VW; Bauer C; Melamed ML
    BMC Nephrol; 2017 Jan; 18(1):28. PubMed ID: 28095805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of type of vascular access in hemodialysis patients.
    Hirth RA; Turenne MN; Woods JD; Young EW; Port FK; Pauly MV; Held PJ
    JAMA; 1996 Oct 23-30; 276(16):1303-8. PubMed ID: 8861988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrograde femoral vein catheter insertion. A new approach for challenging hemodialysis vascular access.
    Gouda Z
    J Vasc Access; 2014; 15(6):529-36. PubMed ID: 25041920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost of hemodialysis in Iran.
    Arefzadeh A; Lessanpezeshki M; Seifi S
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):307-11. PubMed ID: 19237828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation of hemodialysis: implications for technology assessment in Greece.
    Kaitelidou D; Ziroyanis PN; Maniadakis N; Liaropoulos LL
    Int J Technol Assess Health Care; 2005; 21(1):40-6. PubMed ID: 15736513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Structure of treatment expenditures for hemodialysis patients (data of Kaunas University of Medicine Hospital in the year 2001)].
    Vaiciūniene R; Kuzminskis V; Sileikiene E; Proseviciūte L
    Medicina (Kaunas); 2003; 39 Suppl 1():126-30. PubMed ID: 12761434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. End-stage renal disease in India and Pakistan: burden of disease and management issues.
    Sakhuja V; Sud K
    Kidney Int Suppl; 2003 Feb; (83):S115-8. PubMed ID: 12864888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.
    Plantinga LC; Lim SS; Patzer RE; Pastan SO; Drenkard C
    BMC Nephrol; 2016 Jul; 17(1):64. PubMed ID: 27388761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of physician payment reform on provision of home dialysis.
    Erickson KF; Winkelmayer WC; Chertow GM; Bhattacharya J
    Am J Manag Care; 2016 Jun; 22(6):e215-23. PubMed ID: 27355909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of Chronic Kidney Disease Patients on the Basis of Referral to Nephrologist: A One-Year Follow-up Study.
    Anees M; Hussain Y; Ibrahim M; Ilahi I; Ahmad S; Asif KI; Jameel A
    J Coll Physicians Surg Pak; 2018 Apr; 28(4):304-307. PubMed ID: 29615173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers to the delivery of adequate hemodialysis in ESRD Network 4.
    Palevsky PM; Washington MS; Stevenson JA; Rohay JM; Dyer NJ; Lockett R; Perry SB
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S11-20. PubMed ID: 11053582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of outpatient kidney function recovery among patients who initiate hemodialysis in the hospital.
    Hickson LJ; Chaudhary S; Williams AW; Dillon JJ; Norby SM; Gregoire JR; Albright RC; McCarthy JT; Thorsteinsdottir B; Rule AD
    Am J Kidney Dis; 2015 Apr; 65(4):592-602. PubMed ID: 25500361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infrequent dialysis: a new paradigm for hemodialysis initiation.
    Rhee CM; Unruh M; Chen J; Kovesdy CP; Zager P; Kalantar-Zadeh K
    Semin Dial; 2013; 26(6):720-7. PubMed ID: 24016197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. For-profit versus not-for-profit dialysis care for children with end stage renal disease.
    Furth SL; Hwang W; Neu AM; Fivush BA; Powe NR
    Pediatrics; 1999 Sep; 104(3 Pt 1):519-24. PubMed ID: 10469779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.